Host-Microbe Interplay in the Cardiometabolic Benefits of Dietary Polyphenols

Research output: Contribution to journal › Review › Research › peer-review

Standard

Host-Microbe Interplay in the Cardiometabolic Benefits of Dietary Polyphenols. / Anhê, F F; Choi, B S Y; Dyck, J R B; Schertzer, J D; Marette, A.

In: Trends in Endocrinology and Metabolism, Vol. 30, No. 6, 06.2019, p. 384-395.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Anhê, FF, Choi, BSY, Dyck, JRB, Schertzer, JD & Marette, A 2019, 'Host-Microbe Interplay in the Cardiometabolic Benefits of Dietary Polyphenols', Trends in Endocrinology and Metabolism, vol. 30, no. 6, pp. 384-395. https://doi.org/10.1016/j.tem.2019.04.002

APA

Anhê, F. F., Choi, B. S. Y., Dyck, J. R. B., Schertzer, J. D., & Marette, A. (2019). Host-Microbe Interplay in the Cardiometabolic Benefits of Dietary Polyphenols. Trends in Endocrinology and Metabolism, 30(6), 384-395. https://doi.org/10.1016/j.tem.2019.04.002

Vancouver

Anhê FF, Choi BSY, Dyck JRB, Schertzer JD, Marette A. Host-Microbe Interplay in the Cardiometabolic Benefits of Dietary Polyphenols. Trends in Endocrinology and Metabolism. 2019 Jun;30(6):384-395. https://doi.org/10.1016/j.tem.2019.04.002

Author

Anhê, F F ; Choi, B S Y ; Dyck, J R B ; Schertzer, J D ; Marette, A. / Host-Microbe Interplay in the Cardiometabolic Benefits of Dietary Polyphenols. In: Trends in Endocrinology and Metabolism. 2019 ; Vol. 30, No. 6. pp. 384-395.

Bibtex

@article{4ff6a98de93b4883b74fe8ba1ff02c6f,
title = "Host-Microbe Interplay in the Cardiometabolic Benefits of Dietary Polyphenols",
abstract = "Polyphenols are nonessential phytonutrients abundantly found in fruits and vegetables. A wealth of data from preclinical models and clinical trials consistently supports cardiometabolic benefits associated with dietary polyphenols in murine models and humans. Furthermore, a growing number of studies have shown that specific classes of polyphenols, such as proanthocyanidins (PACs) and ellagitannins, as well as the stilbenoid resveratrol, can alleviate several features of the metabolic syndrome. Moreover, mounting evidence points to the gut microbiota as a key mediator of the health benefits of polyphenols. In this review we summarize recent findings supporting the beneficial potential of polyphenols against cardiometabolic diseases, with a focus on the role of host-microbe interactions.",
keywords = "Animals, Cardiovascular Diseases/metabolism, Gastrointestinal Microbiome/physiology, Humans, Hydrolyzable Tannins/metabolism, Polyphenols/metabolism, Proanthocyanidins/metabolism, Resveratrol/metabolism",
author = "Anh{\^e}, {F F} and Choi, {B S Y} and Dyck, {J R B} and Schertzer, {J D} and A Marette",
note = "Copyright {\textcopyright} 2019 Elsevier Ltd. All rights reserved.",
year = "2019",
month = jun,
doi = "10.1016/j.tem.2019.04.002",
language = "English",
volume = "30",
pages = "384--395",
journal = "Trends in Endocrinology and Metabolism",
issn = "1043-2760",
publisher = "Elsevier Ltd. * Trends Journals",
number = "6",

}

RIS

TY - JOUR

T1 - Host-Microbe Interplay in the Cardiometabolic Benefits of Dietary Polyphenols

AU - Anhê, F F

AU - Choi, B S Y

AU - Dyck, J R B

AU - Schertzer, J D

AU - Marette, A

N1 - Copyright © 2019 Elsevier Ltd. All rights reserved.

PY - 2019/6

Y1 - 2019/6

N2 - Polyphenols are nonessential phytonutrients abundantly found in fruits and vegetables. A wealth of data from preclinical models and clinical trials consistently supports cardiometabolic benefits associated with dietary polyphenols in murine models and humans. Furthermore, a growing number of studies have shown that specific classes of polyphenols, such as proanthocyanidins (PACs) and ellagitannins, as well as the stilbenoid resveratrol, can alleviate several features of the metabolic syndrome. Moreover, mounting evidence points to the gut microbiota as a key mediator of the health benefits of polyphenols. In this review we summarize recent findings supporting the beneficial potential of polyphenols against cardiometabolic diseases, with a focus on the role of host-microbe interactions.

AB - Polyphenols are nonessential phytonutrients abundantly found in fruits and vegetables. A wealth of data from preclinical models and clinical trials consistently supports cardiometabolic benefits associated with dietary polyphenols in murine models and humans. Furthermore, a growing number of studies have shown that specific classes of polyphenols, such as proanthocyanidins (PACs) and ellagitannins, as well as the stilbenoid resveratrol, can alleviate several features of the metabolic syndrome. Moreover, mounting evidence points to the gut microbiota as a key mediator of the health benefits of polyphenols. In this review we summarize recent findings supporting the beneficial potential of polyphenols against cardiometabolic diseases, with a focus on the role of host-microbe interactions.

KW - Animals

KW - Cardiovascular Diseases/metabolism

KW - Gastrointestinal Microbiome/physiology

KW - Humans

KW - Hydrolyzable Tannins/metabolism

KW - Polyphenols/metabolism

KW - Proanthocyanidins/metabolism

KW - Resveratrol/metabolism

U2 - 10.1016/j.tem.2019.04.002

DO - 10.1016/j.tem.2019.04.002

M3 - Review

C2 - 31076221

VL - 30

SP - 384

EP - 395

JO - Trends in Endocrinology and Metabolism

JF - Trends in Endocrinology and Metabolism

SN - 1043-2760

IS - 6

ER -

ID: 335350906